Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_EFE5644700C1
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
UNIL/CHUV
Title
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
Journal
Annals of the Rheumatic Diseases
Author(s)
Furst D.E., Keystone E.C., So A.K., Braun J., Breedveld F.C., Burmester G.R., De Benedetti F., Dörner T., Emery P., Fleischmann R., Gibofsky A., Kalden J.R., Kavanaugh A., Kirkham B., Mease P., Rubbert-Roth A., Sieper J., Singer N.G., Smolen J.S., Van Riel P.L., Weisman M.H., Winthrop K.L.
ISSN
1468-2060 (Electronic)
ISSN-L
0003-4967
Publication state
Published
Issued date
2013
Volume
72
Number
Suppl. 2
Pages
ii2-i34
Language
english
Notes
Publication types: Consensus Development Conference ; Journal ArticlePublication Status: ppublish
Keywords
Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/therapeutic use, Antirheumatic Agents/adverse effects, Antirheumatic Agents/therapeutic use, Female, Humans, Immunoconjugates/adverse effects, Immunoconjugates/therapeutic use, Immunosuppressive Agents/adverse effects, Immunosuppressive Agents/therapeutic use, Male, Polyethylene Glycols/adverse effects, Polyethylene Glycols/therapeutic use, Pregnancy, Rheumatic Diseases/complications, Rheumatic Diseases/drug therapy, Treatment Outcome, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Urate Oxidase/adverse effects, Urate Oxidase/therapeutic use
OAI-PMH
oai:serval.unil.ch:BIB_EFE5644700C1
DOI
10.1136/annrheumdis-2013-203348
Pubmed
23532441
Web of science
000316826300002
Create date
14/01/2014 14:37
Last modification date
20/08/2019 17:17
Usage data